ArticleJournal of experimental & clinical cancer research : CR2025

Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma.

Stefania Elena Navone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.